INNOVATION AND QUALITY
ACTAR IS AN INTEGRATED PART of the innovation system of Karolinska Institutet (KI), giving us unique access to world-class life science innovations from KI as well as many other leading universities throughout the Nordic region. We are dedicated to bring ground-breaking academic inventions to the market.
ACTAR’S DEDICATED STAFF AND MANAGEMENT has significant international experience from academia, biotech and big pharma - we know our business. Actar runs state-of-the art screening and biology laboratories in Stockholm and medicinal chemistry laboratories in Uppsala. We use an extensive network of consultants and contract research organizations. Actar holds the resources to span the drug discovery process from target validation, lead optimization and proof-of-concept in relevant in vivo models to preclinical drug development.
ACTAR FORMS PARTNERSHIPS with the academic inventors for close collaboration during a milestone-driven progression of the drug discovery project - ensuring relevance, highest quality and focus on delivery. To facilitate the exit process, subsidiaries are formed around promising projects.
ALL OF OUR PROJECTS ARE INNOVATIVE, meet significant medical needs and have potential to generate first-in-class medicines with high commercial impact. Actar can offer in-licensing and co-development opportunities for projects in preclinical discovery- and development stages.